Journal of Experimental & Clinical Cancer Research

Journal of Experimental & Clinical Cancer Research 由 BioMed Central 出版，属中科院医学大类（2025 升级版1区，Top 期刊）。按 OpenAlex 近年发文统计，该刊主要发表 Cancer-related molecular mechanisms research、MicroRNA in disease regulation、Cancer Cells and Metastasis 等主题的论文，这 3 个主题约占 23.9%，主导子领域为 Cancer Research、Molecular Biology。（根据 OpenAlex 主题统计与中科院分区数据生成）

• 发表有关基础、临床和转化肿瘤学研究各个方面的研究 • 意大利雷吉纳埃莱纳国家癌症研究所官方期刊 • BMC是开放获取出版先行者,推动开放透明的科研传播 Springer Nature 致力于支持研究人员推动科学进展, 通过可信赖的期刊、严谨的编辑标准以及倡导开放性、科研诚信与研究影响力的全球学术社区, 助力研究成果被广泛传播与认可。

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that publishes original research papers, reviews and commentaries in cancer research, from bench to bedside. Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer. Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation. The following criteria provide an overview of the types of studies considered by the journal: Findings that have not been previously published in the same tumor model. Studies performed in multiple cell lines. Conclusions that are not representative of incremental findings. Studies that include a clearly written title and abstract that communicate the study's impact of significance to non-experts. The online appearance of Journal of Experimental & Clinical Cancer Research allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community. Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that publishes original research papers, reviews and commentaries in cancer research, from bench to bedside. Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer. Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; tumor immunotherapy; large-scale molecular characterization of human tumo

摘自期刊官网 Aims & Scope

研究方向（LetPub）：医学-肿瘤学

主编 Mauro Castelli出版商官网

编委会国家分布：中国大陆 1 位（约 2%）；主要国家 意大利 27、美国 11、德国 3、英国 2、法国 2（共 58 位编委标注了国家） 编委会 ↗出版商官网 · 2026-09-29

中科院期刊分区表

数据库收录

SCIEScopusDOAJLetPub

国际期刊预警名单：各版本均未列入LetPub

期刊官网自述收录

MEDLINEEmbaseCAS出版商官网

其他：Google Scholar、ProQuest、Dimensions、CNKI、Baidu、Naver、OCLC、Portico、CLOCKSS

期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

14.28LetPub · 2026-09-13

影响因子（出版商公布） 2025

14.3出版商官网 · 2026-09-29

五年影响因子（出版商公布） 2025

14.3出版商官网 · 2026-09-29

CiteScore 2026-06

22.3LetPub · 2026-09-13

SJR 2026-06

3.73LetPub · 2026-09-13

SNIP 2026-06

2.27LetPub · 2026-09-13

h-index

67LetPub · 2026-09-13

h-index

186OpenAlex · 2026-10-01

i10-index

3,650OpenAlex · 2026-10-01

两年平均被引

12.97OpenAlex · 2026-10-01

自引率

1.4%LetPub · 2026-09-13

Gold OA 文章占比

99.89%LetPub · 2026-09-13

发文规模

年文章数

317LetPub · 2026-09-13

年下载量（出版商公布） 2025

5,900,000出版商官网 · 2026-09-29

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

平均1月LetPub · 2026-09-13

平均录用比例（社区反馈）

66.66%LetPub · 2026-09-13

投稿到首次决定

3 天出版商官网 · 2026-09-29

投稿到发表（期刊自报）

约 8 周DOAJ · 2026-10-11

评审方式

单盲同行评审DOAJ

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

• APC 费用说明 ↗DOAJ
• 费用减免政策 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

BioMed Central

出版国家或地区

ITALY

出版语言

English

出版周期

Quarterly

创刊年份

2008

ISSN

1756-9966

官方链接

• 期刊主页 ↗DOAJ
• 投稿系统 ↗出版商官网
• 作者指南 ↗LetPub
• Aims & Scope ↗LetPub
• 专刊 / 特刊征稿 ↗出版商官网
• APC 费用说明 ↗DOAJ
• 费用减免政策 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ
• 评审流程 ↗LetPub
• 编委会 ↗LetPub
• 查重政策 ↗DOAJ